Covid Variants

Are they a problem?

As of today we have preliminary prints on “Elsevier“:

The efficacy of ChAdOx1 nCoV-19 against the B.1.1.7 variant of SARS-CoV-2 is similar to the efficacy of the vaccine against other lineages. Furthermore, vaccination with ChAdOx1 nCoV-19 results in a reduction in the duration of shedding and viral load, which may translate into a material impact on the transmission of disease.

Translation: No, the Covid 19 Variants are not a problem. For Astra Zeneca vaccine at least.

Please proceed to the original article

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.